Didanosine (ddl) and stavudine (d4T): Absence of peripheral neurotoxicity in rabbits

W. A. Warner, C. L. Bregman, C. R. Comereski, J. C. Arezzo, T. J. Davidson, C. A. Knupp, S. Kaul, S. K. Durham, A. J. Wasserman, J. D. Frantz

Research output: Contribution to journalArticlepeer-review

13 Scopus citations


Some 20 male New Zealand White rabbits (five/group) were given either didanosine (ddl) or stavudine (d4T) at 750 and 1500 mg/kg body weight/day by oral intubation for 24 wk. An additional group was given 300 mg/kg body weight/day zidovudine (AZT) as a negative control. After 13 weeks the high dose of ddl was lowered from 1500 to 1000 mg/kg body weight/day following the death of one rabbit and continued inappetence in the dose group. The rabbits were observed daily, plasma drug levels were monitored, and electrophysiological measurements of peripheral nerve conduction were performed during the study. Additionally, body weight and food intake were recorded, and clinicopathological parameters were evaluated. Sections of selected peripheral nerves, and dorsal and ventral spinal nerve roots were examined by light and transmission electron microscopy. Although peripheral neuropathy has been reported in rabbits with the nucleoside analogue zalcitabine (ddC), based on clinical observations, electrophysiological measurements, and light and electron microscopy, no evidence of peripheral neurotoxicity was observed in rabbits given either ddl or d4T.

Original languageEnglish (US)
Pages (from-to)1047-1050
Number of pages4
JournalFood and Chemical Toxicology
Issue number12
StatePublished - Dec 1995

ASJC Scopus subject areas

  • Food Science
  • Toxicology


Dive into the research topics of 'Didanosine (ddl) and stavudine (d4T): Absence of peripheral neurotoxicity in rabbits'. Together they form a unique fingerprint.

Cite this